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Small RNA sequencing (sRNA-seq) can be used to detect viruses in infected hosts without the necessity to have any prior knowledge
or specialized sample preparation.The sRNA-seq method was initially used for viral detection and identification in plants and then
in invertebrates and fungi. However, it is still controversial to use sRNA-seq in the detection of mammalian or human viruses. In
this study, we used 931 sRNA-seq runs of data from the NCBI SRA database to detect and identify viruses in human cells or tissues,
particularly from some clinical samples. Six viruses including HPV-18, HBV, HCV, HIV-1, SMRV, and EBV were detected from
36 runs of data. Four viruses were consistent with the annotations from the previous studies. HIV-1 was found in clinical samples
without the HIV-positive reports, and SMRV was found in Diffuse Large B-Cell Lymphoma cells for the first time. In conclusion,
these results suggest the sRNA-seq can be used to detect viruses in mammals and humans.
1. Introduction
Infection by pathogens is one of the main risk factors for
manydiseases [1–4], particularly for cancers. In 2008, approx-
imately two million new cancer cases (16%) worldwide were
caused by pathogen infection. Most cancers inducing infec-
tious agents were viruses [5], including Epstein-Barr virus
(EBV), hepatitis B and C virus (HBV andHCV, resp.), Kaposi
sarcoma herpes virus (KSHV, also known as human herpes
virus type 8, HHV-8), human immunodeficiency virus type
1 (HIV-1), human papillomavirus type 16 (HPV-16), and
human T-cell lymphotropic virus type 1 (HTLV-1).Therefore,
the rapid and accurate detection and identification of these
viruses is essential to human health. Conventional detection
methods (e.g., ELISA, PCR, or microarrays) cannot be used
in some cases due to failure to satisfy certain requirements
(e.g., prior knowledge of the potential pathogen or the ability
to cultivate and purify the pathogen [6]). In addition, they
are time-consuming and difficult to use in detection of highly
divergent or novel viruses.
To overcome these limitations, next generation sequenc-
ing (NGS) technologies have been applied for virus and
viroid discovery in plants and animals [7, 8]. Compared
to other NGS based methods requiring the use of viral
enrichment and concentration procedures [7], the small RNA
sequencing (sRNA-seq) based method simplifies the virus
detection, with the aid of virus fragments enriched by the
RNA interference (RNAi) mechanism. RNAi is a cytoplasmic
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cell surveillance system which recognizes double-stranded
RNA (dsRNA) and specifically destroys single-stranded RNA
and dsRNA molecules homologous to the dsRNA inducer,
using small interfering RNAs (siRNAs) as a guide [9]. The
abundant siRNAs accumulated during the RNAi process
facilitate virus detection and the study of RNAi mechanism.
RNAi has been proposed as a key antiviral intrinsic immune
response in plants, nematodes, and arthropods [10]. Based on
such theory, the sRNA-seq method was originally used for
viral detection and identification in plants [8, 11, 12] and in
invertebrates [13–15], but not in mammals or humans. There
was evidence that antiviral RNAi functions in mammalian
germ cells and embryonic stem cells (ESCs), as well as some
carcinoma cell lines [10]. No evidence had been provided to
prove RNAi functions in mammalian somatic cells until Li
et al.’s work was published [16]. Although Li et al. discovered
low level siRNA duplexes in the baby hamster kidney 21 cells,
the role of RNAi in viral defence in mammalians remains
controversial. Therefore, using sRNA-seq to detect viruses in
mammals and humans is a highly promising but hard topic.
In this study, we used 931 sRNA-seq runs of data from
the NCBI SRA database [17] to detect and identify viruses in
human cells or tissues, particularly from some clinical sam-
ples.These tissues came from saliva, tongue, laryngopharynx,
oropharynx, prefrontal cortex, liver, cervix, serum, plasma,
lymph, and so forth. As a result, six viruses includingHPV-18,
HBV, HCV, HIV-1, SMRV (squirrel monkey retrovirus), and
EBVwere detected from36 runs of data. In brief, the existence
of HPV-18, HBV, HCV, and EBV was consistent with the
findings from the original studies, whereas HIV-1 and SMRV
had not been identified previously in the experimental sam-
ples. The nucleotide polymorphism, read-enriched regions
(hotspots), and RNAi responses of detected viruses were
analyzed, following the detection of these viruses.
2. Materials and Methods
Using NCBI SRA advanced searching tools (http://www.ncbi
.nlm.nih.gov/sra/advanced), we retrieved 2,820 runs of data
by the combined keywords including Illumina, small RNA,
and Homo sapiens (November 1, 2014). We subsequently fil-
tered these data based on the following criteria: (1) to
remove non-small RNA-seq data by reading the annotations;
(2) to remove data containing keyword “cell line”; (3) to
remove data from cDNA library selection during library con-
struction. Ultimately, we used 931 runs of data from 42 pre-
vious studies in this study (Table 1).
The software Fastq clean [18] was used for sRNA data
cleaning and quality control. To detect and identify viruses
using sRNA-seq data, we developed an automatic pipeline
using Perl scripts. This pipeline had performed well in the
detection and identification of plant and insect viruses in
our previous studies [12, 19–21].The pipeline integrated three
sequence databases: The first one was an rRNA database,
which was built based on the SILVA ribosomal RNA gene
database [22]. The second one was the human host genome
for the subtraction of host genome sequences. The last one
contained the Vertebrata viral sequences constructed from
the NCBI GenBank database, version 197. The relationship
information between the virus genus and the host was
from the International Committee on Taxonomy of Viruses
(ICTV). For some virus genera which did not have host
information assigned to them, we were able to assign host
categories after reading their NCBI annotations.
For each detected virus, we assigned a putative reference
genome from the NCBI GenBank database to represent the
virus (Supplementary File 1 in Supplementary Material avail-
able online at http://dx.doi.org/10.1155/2016/2596782). We
used the reference genome coverage and the average depth to
quantify the detected viruses. The genome coverage repre-
sents the proportion of read-covered positions against the
genome length. The average depth is equal to the total
base pairs of the aligned reads divided by the read-covered
positions on the reference genome (Tables 2 and 3).
3. Results and Discussion
3.1. HPV-18 from HeLa Cell Lines. To test our virus detection
pipeline, we used HeLa cell line data from the previous
study SRP001381 as positive controls (Table 1). The HeLa
cell line, derived from cervical cancer cells of the patient
Henrietta Lacks, contains HPV-18, one of the carcinogenic
HPV genotypes. In this study, HPV-18 was detected in
all of the three runs of data (SRR031635, SRR031636, and
SRR031637). The assembled HPV-18 in the data SRR031636
covered 74.1% of the reference genome M20325 with an
average depth 8.5. The 19 long viral contigs (≥ 40 bp) covered
62.5% of the reference genome with a uniform distribution
(Supplementary File 1).
3.2. HBV and HCV from Human Liver and HCC Tissues.
Chronic hepatitis B virus (HBV) is one of the first viruses to
be causally linked to a human tumor and is a major global
cause of hepatocellular carcinoma (HCC). HBV, hepatitis C
virus (HCV), and cirrhosis between them contribute to the
genesis of almost all global HCCs [23]. Conventional clinical
tests use markers at the protein level, including the HBV
surface antigen (HBsAg), HBV envelope antigen (HBeAg),
and HBV core antigen (HBcAg) and their antibodies from
the patients’ serum. However, these protein markers are not
always present for various reasons [23].
In the previous study SRP002272 from the NCBI SRA
database (Table 2), 15 clinical samples had been sequenced
including three normal liver tissues, one HBV-infected liver
tissue, one severe chronic hepatitis B liver tissue, two HBV-
positive HCC tissues, one HCV-positive HCC tissue, and
one HCC tissue without HBV or HCV [24]. In this study,
the detection and identification results in 15 runs of data
were consistent with the findings from the previous study
SRP002272 with one exception SRR039619 (Table 2). The
sRNA data SRR039619 from a HBV-positive HCC patient
should have contained HBV but it was not found by our
pipeline. SRR039619 contained 9,161,157 reads, which possibly
were not deep enough to catch adequate virus derived small
RNAs (vsRNAs) for detection.
The assembled HBV in the data SRR039620 covered
54.6% of the reference genome JQ688404 with an average
depth 6 (Supplementary File 1). In the data SRR039620, seven
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Table 1: The 42 previous studies from the SRA database.
Study ID Runs Sample source Disease
DRP000998 3 Whole saliva, salivary exosome Healthy
ERP001908 63 Tongue, laryngopharynx, oropharynx HNSCC
ERP004592 23 Prefrontal cortex Huntington’s disease
SRP001381 3 HeLa cell line HPV18(+)
SRP002118 14 Hek293T cell line NA
SRP002272 15 Liver HBV(+), HCV(+), HCC
SRP002326 38 Cervical tumor Cervical cancer
SRP002402 3 Sperm Healthy
SRP007825 67 Skin Psoriasis
SRP008258 2 Hek293, HeLa cell line NA
SRP009246 4 Primary human fibroblast NA
SRP014020 20 Thyroid tumor Follicular thyroid adenoma
SRP017809 4 Dorsolateral prefrontal cortex Healthy
SRP017979 4 Colorectal tumor Colorectal cancer
SRP018255 35 Plasma, serum, placenta Healthy
SRP021130 20 Cerebral cortex FTLD, PSP, BHS, DLB,Alzheimer’s disease
SRP021193 40 Heart NIC, IC
SRP021911 12 Cumulus granulosa cell, mural granulosa cell NA
SRP021924 5 Brain frontal cortex NA
SRP022043 70 Blood Alzheimer’s disease
SRP022054 26 Sigma, liver, coecum, colon ascendens, lymph
node Colorectal cancer
SRP026081 2 Penicillium marneffei NA
SRP026558 2 PBMC Osteopetrosis
SRP026562 11 Prefrontal cortex Alzheimer’s disease
SRP027589 42 Serum Breast cancer
SRP028291 78 ACA, ACC tumor, adrenal tissue ACA, ACC
SRP028738 16 MiRQC, serum, liver NA
SRP029599 9 FFPE, serum Nonkeratinizing NPC, NPC
SRP032650 4 Serum Latent PTB, PTB
SRP032953 12 Alpha cell, beta cell, whole islet Type 2 diabetes mellitus
SRP033505 3 Plasma Healthy
SRP033566 185
Connective tissue, plasma, neuronal tissue,
primary cell, cardiac muscle, epithelium, skeletal
muscle
DCM, IC
SRP034547 4 Primary fibroblast Microcephaly
SRP034586 24 Serum, PBMC Healthy
SRP034590 14 Plasma NA
SRP034654 12 Tensor fascia lata, quadricep vastus, vastus
externe, rhomboid, iliopsoas FSHD
SRP034698 8 Skin, lymph node MCC, SCC, melanoma, BCC
SRP040421 12 Exosome in human semen Healthy
SRP041082 2 Seminal fluid Prostate cancer
SRP046046 12 Lymphoblastoid DLBCL, Burkitt’s lymphoma,EBV(+)
SRP046234 2 Breast epithelium Triple negative breast cancer
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Table 1: Continued.
Study ID Runs Sample source Disease
SRP048290 6 Platelet Healthy
“Study ID” is uniq for each high-throughput project in the NCBI SRA database. ACA: adrenal cortical adenoma, ACC: adrenal cortical carcinoma, BCC:
Basal Cell Carcinoma, BHS: bilateral hippocampal sclerosis, DCM: Dilated Cardiomyopathy, DLB: dementia with Lewy bodies, DLBCL: Diffuse Large B-
Cell Lymphoma, FSHD: Facioscapulohumeral Muscular Dystrophy, FTLD: frontotemporal lobar dementia, HCC: HBV-related hepatocellular carcinoma,
HNSCC: Head and Neck Squamous Cell Carcinoma, IC: Ischemic Cardiomyopathy, MCC: Merkel Cell Carcinoma, NIC: Nonischemic Cardiomyopathy,
NPC: nasopharyngeal carcinoma, PBMC: Peripheral Blood Mononuclear Cell, PSP: Progressive Supranuclear Palsy, PTB: Pulmonary Tuberculosis, and SCC:
Squamous Cell Carcinoma.
Table 2: HBV and HCV from the SRP002272 study.
Run ID Sample Source Reference Cov (%) Depth
SRR039611 Human Normal Liver Tissue NA NA NA
SRR039612 Human Normal Liver Tissue NA NA NA
SRR039613 Human Normal Liver Tissue NA NA NA
SRR039614 HBV-Infected Liver Tissue JQ688405 423 (13.2) 3.0
SRR039615 Severe Chronic Hepatitis B Liver Tissue NA NA NA
SRR039616 HBV(+) Distal Tissue NA NA NA
SRR039617 HBV(+) Adjacent Tissue NA NA NA
SRR039618 HBV(+) Side Tissue NA NA NA
SRR039619∗ HBV(+) HCC Tissue NA NA NA
SRR039620 HBV(+) Adjacent Tissue JQ688404 1756 (54.6) 6.0
SRR039621 HBV(+) HCC Tissue GQ475344 321 (10) 1.5
SRR039622 HCV(+) Adjacent Tissue D85516 1032 (10.8) 1.8
SRR039623 HCV(+) HCC Tissue GU133617 805 (8.3) 8.0
SRR039624 HBV(−) HCV(−) Adjacent Tissue NA NA NA
SRR039625 HBV(−) HCV(−) HCC Tissue NA NA NA
“Run ID” is uniq for each high-throughput fastq file in theNCBI SRA database. “Reference” uses the NCBIGenBank accession number. “Cov (%)” and “Depth”
represent the genome coverage and the average depth, respectively. “Side Tissue” is close to the border between the tumor tissues and the normal tissues but
0–2 cm far from the tumor tissues. “Adjacent Tissue” is the normal tissues 2–5 cm far from the tumor tissues. “Distal Tissue” is the normal tissues at least 10 cm
far from the tumor tissues. “SRR039619∗” should have contained HBV but it was not found by our pipeline.
Table 3: SMRV and EBV from the SRP046046 study.
Run ID Sample Source Reference Cov (%) Depth
SRR1563015 DLBCL M23385 8714 (99.2) 146.1
SRR1563017 DLBCL Exosome M23385 8732 (99.4) 494.5
SRR1563018 EBV(+) BL KC207813 2765 (1.6) 29.2
SRR1563056 EBV(+) BL Exosome KC207813 33107 (19.3) 9.6
SRR1563057 EBV(−) BL NA NA NA
SRR1563058 EBV(−) BL Exosome NA NA NA
SRR1563059 EBV(+) LCL KC207813 13757 (8) 358.2
SRR1563060 EBV(+) LCL Exosome M80517 7444 (4) 288.8
SRR1563061 EBV(+) LCL M80517 18688 (10.2) 151.1
SRR1563062 EBV(+) LCL Exosome KC207814 7931 (4.6) 198.2
SRR1563063 EBV(+) LCL M80517 37898 (20.6) 52.8
SRR1563064 EBV(+) LCL Exosome M80517 57850 (31.4) 17.6
“Run ID” is uniq for each high-throughput fastq file in theNCBI SRA database. “Reference” uses the NCBIGenBank accession number. “Cov (%)” and “Depth”
represent the genome coverage and the average depth, respectively.
long viral contigs (≥ 40 bp) covered the HBV x (HBx), HBV
core (HBc), andHBVpolymerase (HBp) gene regions but did
not cover the HBV surface (HBs) gene region. The long viral
contigs (≥ 40 bp) in the data SRR039614 and SRR039621 only
covered theHBx gene region.The assembledHCV in the data
SRR039622 covered 10.8% of the reference genome D85516
with an average depth 1 (Supplementary File 1). HCVwas also
detected in the data SRR039623 with genome coverage 8.3%
and average depth 1.
3.3. HIV-1 from Breast Cancer Patients. HIV as a member of
the genus Lentivirus causes acquired immunodeficiency syn-
drome (AIDS). As technology evolves, HIV testing assays are
being improved on sensitivity and specificity [25]. However,
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the tests still provide false negative results due to the diag-
nostic window or other reasons [25]. In the previous study
SRP027589 from the NCBI SRA database (Table 1), 42 sam-
ples had been sequenced for the discovery and profiling of
circulating microRNAs in the serum of 42 stage II-III locally
advanced and inflammatory breast cancer (BC) patients [26].
These patients received neoadjuvant chemotherapy (NCT)
followed by surgical tumor resection. However, no AIDS
or HIV-positive results of these patients had been reported
in the previous study SRP027589. In this study, HIV-1 was
detected at a very high level in the data SRR941591. The
assembled HIV-1 in the data SRR941591 covered 39.3% of
the reference genome M19921 with an average depth 210.1
(Supplementary File 1). As far as we know, this was the first
time to report the detection of HIV-1 using sRNA data from
clinical samples.
3.4. SMRV and EBV from B Cells and Exosomes. SMRV, an
endogenous virus of squirrel monkeys, had been isolated by
cocultivation of squirrel monkey lung cells with canine cells
[27]. In previous studies, SMRVhad been detected in Burkitt’s
lymphoma (BL) cell lines [28]. Specifically, the insertion of
the incomplete SMRV proviral genomes had been detected
in Namalwa cell lines [29]. However, we found no reports
that SMRV had been detected in the Diffuse Large B-Cell
Lymphoma (DLBCL). To the best of our knowledge, DLBCL
had only been reported to be caused by EBV [30], HCV [31],
HIV [32], and SV40 (Simian Virus 40) [33].
In this study, SMRV was detected in the data SRR1563015
and SRR1563017 (Table 3). The assembled SMRV in these
two runs of data covered 99.2% and 99.4% of the reference
genome M23385 at an average depth of 146.1 and 494.5,
respectively. In the data SRR1563017, the longest viral contig
was assembled to have a length of 6,760 bp and an identity
99% (6,751/6,764) of the reference sequenceM23385 (Supple-
mentary File 1). As far as we know, this was the first time to
report the detection of SMRV using sRNA data from DLBCL
samples.
Epstein-Barr virus (EBV) has been firmly linked to
some cancers and proliferative diseases, including Burkitt’s
lymphoma (BL), nasopharyngeal carcinoma, immunoblastic
lymphoma, a subset of gastric carcinomas, rare T- and NK-
cell lymphomas or leiomyosarcoma, acute infectious mon-
onucleosis, and Hodgkin’s disease. Almost 100% of BL cases
in Equatorial Africa carry EBV. Children infected early in
life with the highest antibody titres to the virus are at the
highest risk of developing the tumor [34]. EBV-positive BL
predominant in Africa and EBV-negative BL predominant in
Europe and/or the United States have different causation and
characteristics [34].
In the previous study SRP046046 from the NCBI SRA
database, 12 samples had been sequenced to distinguish the
small RNA composition in six B cells from their exosomes.
Six B cells included three EBV-positive lymphoblastoid B
cells (LCLs), one EBV-positive Burkitt’s lymphoma (BL) cell,
one EBV-negative BL cell, and one Diffuse Large B-Cell
Lymphoma (DLBCL) cell. As a result, EBV had been detected
from two EBV-positive BL samples and six EBV-positive
LCL samples (Table 3). In this study, EBV was detected in
the data SRR1563018, SRR1563056, SRR1563059, SRR1563060,
SRR1563061, SRR1563062, SRR1563063, and SRR1563064.
This finding confirmed the results in the previous study
SRP046046. However, the reference genome coverage by
vsRNAs was uneven in eight runs of data varying from 1.6%
to 31.4%.This large variance could result from sample extrac-
tion, small RNA library construction, sequencing quality, or
sequencing depth. In the data SRR1563063, the assembled
EBV contigs covered 20.6% of the reference genome M80517
(Supplementary File 1).
3.5. Nucleotide Polymorphism, Hotspots, and RNAi Responses.
Theplant sRNA-seq data had been shown to contain adequate
information for studying nucleotide polymorphism of the
actual virus [35]. Among the six human viruses found in
this study, HIV-1 in the data SRR941591 showed the highest
nucleotide polymorphism rate covering 2.66% (155/5,831) of
the genomic positions (Figure 1), as compared to SMRV in
the data SRR1563017, EBV in the data SRR1563063, andHPV-
18 in the data SRR031636 covering only 0.41% (36/8,732),
0.29% (110/37,898), and 0.13% (3/2,324) of the genomic
positions, respectively (Supplementary File 2). HIV-1 is a
single-stranded RNA (ssRNA) reverse-transcribing virus.
HIV reverse transcriptase has been shown to be exceptionally
inaccurate [36] andmay explain the high polymorphism rates
observed in this study. HPV-18 and EBV are double-stranded
DNA (dsDNA) viruses which have low error rates during
their replication. SMRV, as ssRNA retrovirus, was expected
to have a high nucleotide polymorphism rate but this was not
reflected in these data. HBV and HCV showed no polymor-
phismwhatsoever, probably due to the low sequencing depth.
Consistent with our previous results in plant virus detec-
tion, the distribution of vsRNA coverage over the human
virus genomes was not even, with some read-enriched
regions (hotspots) in the vsRNA-covered regions on both
of the positive and negative strands (Supplementary File
3). In HPV-18, HBV, HCV, and SMRV, the vsRNA-covered
region on the positive strand wasmore than nine times larger
than the vsRNA-covered region on the negative strand, while
HIV-1 and EBV had little difference between vsRNA-covered
regions over the positive and negative strands. Using the data
SRR941591 as an example (Figure 1), the number of bases
covered by vsRNA reads on the HIV-1 positive strand against
the negative strand was 4,961 bp to 3,945 bp with overlap
52.74% (3,075/5,831). There were three obvious hotspots on
the putative HIV-1 reference M19921. The first (779–810 bp)
and second (2,017–2,045 bp) hotspot resided on the HIV-1
positive strand. Different from the first and second hotspot,
the third hotspot (12,006–12,044 bp) consisted of positive-
and negative-strand vsRNAs.
To investigate the RNAi responses using 36 virus-
containing runs of data, we analyzed the length distribution
of the reads aligned to the virus reference sequences. Viral
small RNA read lengths of HIV-1 in the data SRR941591
had the distribution pattern expected from a RNAi response,
similar to what had been found in previous studies [16].
This pattern consists of positive- and negative-strand vsRNAs
with countable values at the 21, 22, 23, and 24 bp read
length (Figure 2). Another characteristic of RNAi responses
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Figure 1: Nucleotide polymorphism, hotspots, and siRNA duplexes of HIV-1.The 𝑥-axis represents positions on the HIV-1 reference genome
(GenBank: M19921).The 𝑦-axis represents the read counts from the data SRR941591 on each position.The dots in the top black box represent
positions with polymorphic nucleotides. #1, #2, and #3 are the size distributions of positive- and negative-strand viral reads in hotspot 1 (779–
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is that there must be positive- and negative-strand vsRNAs
in some hotspots. In the data SRR941591, the third hotspot
satisfied this criterion. The last and key step to identify
RNAi responses is to find the siRNA duplexes from hotspots.
They are usually only a minute fraction of the total vsRNAs,
because the duplexes are short lived, due to one of the two
strands being rapidly degraded following their creation. In
the third hotspot, we found three canonical 22 bp siRNA
duplexes containing a 20 nt perfectly base-paired duplex
region with 2 nt 3󸀠 overhangs. We also found 21, 23, and
24 bp siRNA-like duplexes, respectively (Figure 1). However,
we used the putativeHIV-1 referenceM19921 for this analysis,
BioMed Research International 7
gccgggcggccgccggtgggtcCGCTGGGCCGCTGCCCCGCTCC
GGGTGGGGGGTGGCCCCGCTGGGCACCGCTGCGCCGCCGCCAGGT
10
G G
G
G G G
G
G G GG
G
G G G
G G
G
G G G G
G G
G
G G G
G GG G
G
G G
GG
GGGG C C
C C C C
C
C
CCCC
C
CC C
C
C C C
C C C CC C C C
C
C
C
C
C C
C
C U
U
U
U
U
U
U
U
UU A
A
Predicted miRNA precursor sequence, 90bp, dG = −69.8 [initially − 69.3]
5
󳰀
3
󳰀
(a)
0 35000
50578 50702 50827 50952 51077 51202 51327 51452 51577 51702 51827 51952 52077
52115
50578 CCGCCAGGTCCTGGGGCAGCCGGGGTTCCTGGCGCTCCGGGGGCAgccgggcggccgccggtgggtc
CGCTGGGCCGCTGCCCCGCTCCGGGTGGGGGGTGGCCCCGCTGGGCACCGCTGCGCCG50645
50664
50702
70000
EBV reference genome (M80517)
13 repeating regions
13 repeating regions
105000 140000 175000
(b)
Figure 3: The predicted miRNAs of EBV. The EBV detected in data SRR1563063 is represented using the reference genome (GenBank:
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This mature miRNA is repeated 12 times in 13 repeated units.
without knowledge of the exact HIV-1 sequence. M19921
is recombinant clone pNL4-3, which includes the HIV-1
virus region and vector region. Since the pNL4-3 clone is
only constructed for the experiment use, the vsRNAs on
the pNL4-3 vector region could be contamination during
the library construction or sequencing process. Although the
third hotspot existed in the pNL4-3 vector region, rather than
the HIV-1 region on the reference M19921, the reliability of
these siRNA duplexes in the third hotspot was supported by
their uniqueness in the NCBI GenBank database and high
sequencing depth. Therefore, this RNAi response could have
happened in other samples.
In addition to the siRNAs, vsRNAs include other small
RNA reads, for example, microRNAs (miRNAs), piwi-
interacting RNAs (piRNAs), or degraded mRNA fragments.
DNA viruses produce their own miRNAs facilitating the
detection of DNA viruses, for example, EBV. In the data
SRR1563063, we found seven miRNA-like duplexes from
EBV vsRNAs (Supplementary File 3). Then, we blasted these
duplexes to the miRBase database (http://www.mirbase.org/)
and identified three knownmature virus miRNAs.They were
rlcv-mir-rL1-1-3p, ebv-mir-BART1-5p, and ebv-mir-BART1-
3p located at positions 53,801, 151,640, and 151,676 on the
EBV referenceM80517.ThreematuremiRNAs came from two
miRNA precursors (pre-miRNAs) rlcv-mir-rL1-1 and ebv-
mir-BART1. Compared to two other miRNAs, the ebv-mir-
BART1-5p was expressed at a very high level of 17,987 read
counts. As for the remaining four duplexes, we confirmed
they could not be matched to the human genome. Then, we
used RNAfold online server (http://rna.tbi.univie.ac.at/cgi-
bin/RNAfold.cgi) to predict the second structures of their
pre-miRNAs (Supplementary File 4). As a result, we iden-
tified a new EBV pre-miRNA, with a length of 90 bp and a
very high minimal folding free energy index (MEFI) over
1.0 (Figure 3(a)). Furthermore, this pre-miRNA resided in
a repeating region on the reference M80517. This repeating
region from 50,578 to 52,077 bp had 13 units (Figure 3(b)).
Each unit with a length of 125 bp contained this pre-miRNA
sequence. It suggested that this repeating region comprise a
primary miRNA (pri-miRNA).
4. Conclusions
In this study, we used 931 sRNA-seq runs of data from the
NCBI SRA database to detect and identify human viruses.
Six viruses were detected and two of them were not found
in previous studies. These results suggest the sRNA-seq can
be used to detect viruses in mammals and humans. The
sRNA-seq data contains the heterozygosity information that
can be used to investigate the pathogen evolution in one
person and design therapies to deal with a specific virus
population. The sRNA-seq data can also be used to find
new virus miRNA or to investigate the RNAi responses in
mammals and humans. However, sRNA-seq data used in
this study were not from virus-infection experiments with
knowledge of the exact virus sequences. In place of the exact
virus sequences, the putative virus sequences were used to
investigate the RNAi responses. Although using the putative
8 BioMed Research International
virus sequences brought some uncertainties, the results of
this study still shed light on the studies of virus induced RNAi
in mammals.
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